Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsgenetics-dysmorphology-and-metabolism

Paeds SAQs · genetics-dysmorphology-and-metabolism

Noonan syndrome and RASopathies — formative SAQs

Formative SAQs on Noonan syndrome and the RASopathies: recognising the shared RAS/MAPK pathway phenotype, distinguishing Noonan syndrome from the other RASopathies by gene and cardiac profile, confirming with a multigene panel, and applying a genotype-aware surveillance schedule.

20 marks30 min1 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Noonan syndrome and the RASopathies across the lifespan

SAQ 1 (10)

A newborn boy is noted on the postnatal ward to have a triangular face, hypertelorism, ptosis, low-set posteriorly rotated ears, a short webbed neck, and widely spaced nipples. The karyotype is 46,XY. An echocardiogram shows pulmonary valve stenosis with dysplastic leaflets. [1] [3]

a) Define the RASopathies and explain why Noonan syndrome is the prototypical member. State the most likely genetic basis and the appropriate confirmatory test. (3 marks) [1] [2]

b) Outline the newborn-period surveillance items, including the timing and rationale of the cardiac investigation. (3 marks) [3] [1]

c) State the coagulation abnormality that is common in Noonan syndrome and explain why it matters for this child's future management. (2 marks) [1] [3]

d) The parents ask about the recurrence risk for their next child. Both parents are clinically unaffected. State the recurrence risk and explain the reasoning. (2 marks) [1] [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet, 2013.PMID 23312968
  2. [2]Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet, 2001.PMID 11704759
  3. [3]Romano AA, Allanson JE, Dahlgren J, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics, 2010.PMID 20876176
  4. [4]Gelb BD, Cavé H, Dillon MW, et al. ClinGen's RASopathy Expert Panel consensus methods for variant interpretation. Genet Med, 2018.PMID 29493581
  5. [5]Niihori T, Aoki Y, Okamoto N, et al. HRAS mutants identified in Costello syndrome patients can induce cellular senescence. J Hum Genet, 2011.PMID 21850009
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeurofibromatosis type 1 and type 2 — formative SAQsgenetics-dysmorphology-and-metabolismNextOrganic acidaemias — formative SAQsgenetics-dysmorphology-and-metabolism